Harm reduction
We support cessation resources and may emphasize non-hormonal vasomotor therapies while you quit. Be honest about cigarettes and vaping so risk counseling is accurate.
HormoneFit Learn
Medically reviewed by Dr. Nathan Roth, MDCM, FRCSC, FACOG · Updated 2026-11-01
Smoking increases cardiovascular and clot risk and makes estrogen decisions more cautious. Many clinicians avoid or carefully limit systemic estrogen in heavier smokers, especially with other risk factors, and strongly prioritize quitting. If HRT is considered, transdermal estradiol is often preferred over oral estrogen. The best intervention is still smoking cessation. HormoneFit addresses both symptom relief and risk reduction.
We support cessation resources and may emphasize non-hormonal vasomotor therapies while you quit. Be honest about cigarettes and vaping so risk counseling is accurate.
This page is educational and does not replace personalized medical advice. HormoneFit physicians assess each patient individually. Women in Ontario can book a virtual consultation.
Schedule your first visit to discuss your symptoms and goals with a licensed specialist. We'll help you explore your options and tailor solutions to your midlife health.
You can also check out our FAQ.